Evidence mapPaperPMID 41737175Full record

ArticlePakistan journal of medical sciences2026

Evaluation of the relationship between glycated hemoglobin (HbA1c) levels and diabetes and other diseases: A retrospective study.

Olgun Goktas

Abstract read
In one paragraph

Article in Pakistan journal of medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Olgun GoktasDr. Olgun Goktas Associate Professor, Uludag University Family Health Center, 16059, Gorukle Campus-Nilufer, Bursa, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To retrospectively evaluate the relationships between glycated hemoglobin (HbA1c) levels and diabetes and other diseases in primary care. Methodology: This study was conducted retrospectively using the available recorded data of individuals registered with the Bursa Uludag University Family Health Center, and who underwent HbA1c measurement during the five years between January 2020 to December 2024. 3520 Visits (N) constituted the study population. Simple random sampling was at least 385 patients with a 5% error rate and a 95% confidence level. 537 (n) Patients who met the inclusion criteria were included in the study sample. The study's sample power was determined to be 99% and the effect size was determined to be quite high at 0.49. Results: Of the 537 individuals who participated in the study, 117 (21.8%) were female and 420 (78.2%) were male. The average age of the individuals was determined to be 39.29±14.63. Based on the main findings of the study, allergic disease (β=4.62), gender (β=4.45), anemia (β=3.92), and non-pregnancy status (β=3.22) were found to be multiple associations. Patients with these characteristics are at an estimated risk of having an HbA1c level above 6.5 (R Conclusion: In our study, the male gender, older age, genetic and chronic diseases, allergies, anemia and diabetes were significantly different across HbA1c groups. Allergic diseases, gender, anemia and pregnancy were found to have associations affecting HbA1c levels. Our results regarding HbA1c levels in family medicine are crucial for diagnosis, treatment, follow-up and referral to other clinics.

Indexed as

DiabetesDiseasesFamily medicine practiceGlycated hemoglobin (HbA1c)

Identifiers

PMID41737175
PMCPMC12927148

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.